Showing results (251-260 of 297) with videos related to

Sort By:
Pageof 30
Analytica Chimica Acta|April 13, 2020
Differentiation between stages of non-alcoholic fatty liver diseases using surface-enhanced Raman spectroscopyElisa Gurian, Pablo Giraudi, Natalia Rosso, et al.
Clinical Chemistry and Laboratory Medicine|October 7, 2009
SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cellsMarcello Persico, Roberta Russo, Eliana Persico, et al.
Plos One|February 2, 2016
The Biological Effects of Bilirubin PhotoisomersJana Jasprova, Matteo Dal Ben, Eleonora Vianello, et al.
Pediatric Research|May 4, 2021
Screening methods for neonatal hyperbilirubinemia: benefits, limitations, requirements, and novel developmentsChristian V Hulzebos, Libor Vitek, Carlos D Coda Zabetta, et al.
Journal of Translational Medicine|December 12, 2023
The potential role of omentin-1 in obesity-related metabolic dysfunction-associated steatotic liver disease: evidence from translational studiesNoel Salvoza, Pablo Giraudi, Silvia Gazzin, et al.
Plos One|July 9, 2016
An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisVeronica Marin, Natalia Rosso, Matteo Dal Ben, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2004
Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1)Florinda Gennuso, Cristina Fernetti, Cataldo Tirolo, et al.
Pageof 30